Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia

被引:8
|
作者
Saito, Shigeyoshi [1 ,2 ]
Koyama, Yoshihiro [3 ]
Ueda, Junpei [1 ]
Hashido, Takashi [3 ]
机构
[1] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Med Phys & Engn, Osaka 5650871, Japan
[2] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Adv Med Technol, Osaka 5650871, Japan
[3] Osaka Univ Hosp, Dept Med Technol, Div Radiol, Osaka 5648565, Japan
基金
日本学术振兴会;
关键词
histogram-derived ADC parameters; stromal hyperplasia; glandular hyperplasia; prostate cancer; benign prostate hyperplasia; CONTRAST-ENHANCED MRI; LOCAL TREATMENT; GLEASON SCORE; NORMAL TISSUE; GUIDELINES; DIAGNOSIS; DIFFERENTIATION; CELLULARITY; UPDATE; BIOPSY;
D O I
10.3390/diagnostics12020525
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The aim of this paper was to assess the associations between prostate cancer aggressiveness and histogram-derived apparent diffusion coefficient (ADC) parameters and determine which ADC parameters may help distinguish among stromal hyperplasia (SH), glandular hyperplasia (GH), and low-grade, intermediate-grade, and high-grade prostate cancers. The mean, median, minimum, maximum, and 10th and 25th percentile ADC values were determined from the ADC histogram and compared among two benign prostate hyperplasia (BPH) groups and three Gleason score (GS) groups. Seventy lesions were identified in 58 patients who had undergone proctectomy. Thirty-nine lesions were prostate cancers (GS 6 = 7 lesions, GS 7 = 19 lesions, GS 8 = 11 lesions, GS 9 = 2 lesions), and thirty-one lesions were BPH (SH = 15 lesions, GH = 16 lesions). There were statistically significant differences in 10th percentile and 25th percentile ADC values when comparing GS 6 to GS 7 (p < 0.05). The 10th percentile ADC values yielded the highest area under the curve (AUC). Tenth and 25th percentile ADCs can be used to more accurately differentiate lesions with GS 6 from those with GS 7 than other ADC parameters. Our data indicate that the major challenge with ADC mapping is to differentiate between SH and GS 6, and SH and GS 7.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] IS THERE A RELATIONSHIP BETWEEN BENIGN PROSTATIC HYPERPLASIA AND PROSTATIC-CANCER
    PAGANO, F
    ZATTONI, F
    VIANELLO, F
    PIAZZA, R
    CAPITANIO, G
    EUROPEAN UROLOGY, 1991, 20 : 31 - 35
  • [2] The link between benign prostatic hyperplasia and prostate cancer
    David D. Ørsted
    Stig E. Bojesen
    Nature Reviews Urology, 2013, 10 : 49 - 54
  • [3] The Controversial Relationship Between Benign Prostatic Hyperplasia and Prostate Cancer: The Role of Inflammation
    De Nunzio, Cosimo
    Kramer, Gero
    Marberger, Michael
    Montironi, Rodolfo
    Nelson, William
    Schroder, Fritz
    Sciarra, Alessandro
    Tubaro, Andrea
    EUROPEAN UROLOGY, 2011, 60 (01) : 106 - 117
  • [4] Benign prostatic hyperplasia, prostate cancer
    Lebdai, S.
    PROGRES EN UROLOGIE, 2017, 27 (03): : F60 - F62
  • [5] Benign prostatic hyperplasia, prostate cancer
    Mathieu, R.
    PROGRES EN UROLOGIE, 2015, 25 : F82 - F84
  • [6] Benign prostatic hyperplasia, prostate cancer
    Mathieu, R.
    PROGRES EN UROLOGIE, 2016, 26 (01): : F20 - F22
  • [7] BENIGN PROSTATIC HYPERPLASIA AND CANCER OF PROSTATE
    WILLIAMS, RD
    BLACKARD, CE
    LANCET, 1974, 2 (7891): : 1265 - 1265
  • [8] Benign prostatic Hyperplasia, prostate cancer
    Mathieu, R.
    PROGRES EN UROLOGIE, 2016, 26 (03): : F65 - F66
  • [9] Benign prostatic hyperplasia, prostate cancer
    Lebdai, S.
    PROGRES EN UROLOGIE, 2017, 27 (01): : F18 - F20
  • [10] BENIGN PROSTATIC HYPERPLASIA AND CANCER OF PROSTATE
    BYAR, DP
    LANCET, 1975, 1 (7911): : 866 - 866